284
Participants
Start Date
March 31, 2015
Primary Completion Date
March 31, 2017
Study Completion Date
March 31, 2017
Methergine
0.2 mg of methylergonovine maleate
placebo
saline placebo to maintain blinding
SFGH Women's Options Center, San Francisco
University of California, San Francisco
OTHER